Dynatronics Revenue Growth Rates (DYNT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Dynatronics Corporation  (DYNT)
 

DYNT's Revenue Growth by Quarter and Year

Dynatronics's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DYNT Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 7.02
FY 7.02

DYNTs Annual Revenue
Dynatronics's Revenue in the fiscal year 2025 $ 27.39 millions
Dynatronics's Revenue in the fiscal year 2024 $ 32.53 millions
Dynatronics's Revenue in the fiscal year 2023 $ 40.61 millions
Dynatronics's Revenue in the fiscal year 2022 $ 44.34 millions
Dynatronics's Revenue in the fiscal year 2021 $ 47.80 millions




DYNT Revenue first quarter 2025 Y/Y Growth Comment
Dynatronics Corporation reported decrease in Revenue in the first quarter 2025 by -7.58% to $ 7.02 millions, from the same quarter in 2024.
The decrease in the first quarter 2025 Dynatronics Corporation's Revenue compares unfavorably to the Company's average Revenue decrease of -1.1%.

Looking into first quarter 2025 results within Medical Equipment & Supplies industry 136 other companies have achieved higher Revenue growth. While Dynatronics Corporation' s Revenue decline of -7.58% ranks overall at the positon no. 3112 in the first quarter 2025.


DYNT Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June - -13.98 % 0.14 % -34.23 %
3rd Quarter March - -19.71 % -17.1 % -10.47 %
2nd Quarter December - -10.43 % -25.09 % 3.32 %
1st Quarter September -7.58 % -18.72 % -22.41 % -2.03 %
FY   - -15.8 % -17.71 % -

Financial Statements
Dynatronics's first quarter 2025 Revenue $ 7.02 millions DYNT's Income Statement
Dynatronics's first quarter 2024 Revenue $ 7.60 millions Quarterly DYNT's Income Statement


DYNT Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June - 3.09 % -3.79 % -20.35 %
3rd Quarter March - -15.75 % -6.01 % -15.07 %
2nd Quarter December - -3.95 % -12.83 % -9.71 %
1st Quarter September 10.79 % 3.12 % 27.04 % 7.69 %
FY (Year on Year)   - -15.8 % -17.71 % -


Back to DYNT Growth rate Comparisons >> Back to DYNT Growth rate Comparisons >>


Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #137
Healthcare Sector #439
Overall #3112

Revenue Y/Y Growth Statistics
High Average Low
115.58 % -1.1 % -100 %
(Jun 30 2018)   (Jun 30 2025)
Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #137
Healthcare Sector #439
Overall #3112
Revenue Y/Y Growth Statistics
High Average Low
115.58 % -1.1 % -100 %
(Jun 30 2018)   (Jun 30 2025)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Dynatronics's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
49.49 % 0.78 % -40.79 %
(Sep 30 2020)  


DYNT's I. Quarter Q/Q Revenue Comment
Dynatronics Corporation achieved in the I. Quarter 2025 above company average sequential Revenue rise of 10.79%, to $ 7.02 millions, from $6.34 millions in the fourth quarter.
DYNT is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Dynatronics's Revenue growth quarter on quarter, overall rank is 780.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #139
Overall #780
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #139
Overall #780
Revenue Q/Q Growth Statistics
High Average Low
49.49 % 0.78 % -40.79 %
(Sep 30 2020)  


DYNT's I. Quarter Q/Q Revenue Comment
Dynatronics Corporation achieved in the I. Quarter 2025 above company average sequential Revenue rise of 10.79%, to $ 7.02 millions, from $6.34 millions in the fourth quarter.
DYNT is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Dynatronics's Revenue growth quarter on quarter, overall rank is 780.


Dynatronics's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)
Cumulative Revenue 12 Months Ending $ 26.81 $ 27.39 $ 28.43 $ 29.93 $ 30.78
Y / Y Revenue Growth (TTM) -12.89 % -15.8 % -12.58 % -12.21 % -16.41 %
Year on Year Revenue Growth Overall Ranking # 3308 # 2724 # 0 # 641 # 2357
Seqeuential Revenue Change (TTM) -2.11 % -3.64 % -5.03 % -2.76 % -5.38 %
Seq. Revenue Growth (TTM) Overall Ranking # 2200 # 2431 # 0 # 2869 # 1856


Cumulative Revenue growth Comment
Dynatronics showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2025. If the fiscal year would end in Sep 30 2025, Dynatronics's annual Revenue decline would be -12.89% year on year to $27 millions.

In the Healthcare sector 450 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2724 to 3308.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 451
Overall # 3308

Revenue TTM Y/Y Growth Statistics
High Average Low
80.14 %
 0.85 %
-44.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 344
S&P 500 # 2200
Cumulative Revenue growth Comment
Dynatronics showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2025. If the fiscal year would end in Sep 30 2025, Dynatronics's annual Revenue drop would be -12.89% year on year to $27 millions.

In the Healthcare sector 450 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2724 to 3308.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 451
Overall # 3308

Revenue TTM Y/Y Growth Statistics
High Average Low
80.14 %
0.85 %
-44.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 344
S&P 500 # 2200




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DYNT's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2025
Community Health Systems Inc -0.10%$ -0.097 millions
Bioventus Inc -0.23%$ -0.232 millions
Bruker Corporation-0.39%$ -0.394 millions
Charles River Laboratories International inc -0.49%$ -0.486 millions
Protalix Biotherapeutics inc -0.60%$ -0.601 millions
Jaguar Health Inc -0.80%$ -0.804 millions
Bio techne Corp-1.01%$ -1.005 millions
Agilon Health Inc -1.08%$ -1.076 millions
Picard Medical Inc -1.25%$ -1.249 millions
Nexgel Inc -1.71%$ -1.709 millions
Capsovision Inc -1.75%$ -1.753 millions
Utah Medical Products Inc-2.02%$ -2.020 millions
10x Genomics Inc -2.04%$ -2.038 millions
Hyperfine Inc -2.06%$ -2.063 millions
Teladoc Health Inc -2.20%$ -2.197 millions
Lineage Cell Therapeutics Inc -2.59%$ -2.593 millions
Pacific Biosciences Of California Inc -2.83%$ -2.828 millions
Pluri Inc -3.07%$ -3.067 millions
Castle Biosciences Inc -3.19%$ -3.193 millions
Bionexus Gene Lab Corp -3.29%$ -3.291 millions
Nrc Health-3.38%$ -3.381 millions
Prestige Consumer Healthcare Inc -3.46%$ -3.459 millions
Sight Sciences Inc -3.57%$ -3.567 millions
Pediatrix Medical Group Inc -3.58%$ -3.577 millions
Quidelortho Corp-3.74%$ -3.741 millions
Escalon Medical Corp -3.81%$ -3.813 millions
Myriad Genetics Inc -3.98%$ -3.985 millions
Plus Therapeutics Inc -4.05%$ -4.052 millions
Perrigo Company Plc-4.07%$ -4.074 millions
P3 Health Partners Inc -4.66%$ -4.659 millions


About Dynatronics Revenue Growth Rates (DYNT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Dynatronics Corp (CIK 720875).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001062993-25-016938
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Dynatronics Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.